Advertisement
Screener

APTALIS PHARMA INC Costs and Expenses

APTALIS PHARMA INC Costs and Expenses

APTALIS PHARMA INC reported Costs and Expenses of $111.41 million for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-10.

Discontinued › Expense Statement › Operating Expenses

us-gaap:CostsAndExpenses · last filed 2012-02-10

  • APTALIS PHARMA INC costs and expenses for the quarter ending 2011-12-31 was $111.41M, a 66.26% increase year-over-year.
  • APTALIS PHARMA INC costs and expenses for the quarter ending 2011-09-30 was $147.58M, a 122.28% increase year-over-year.
  • APTALIS PHARMA INC costs and expenses for the quarter ending 2011-06-30 was $193.67M, a 140.39% increase year-over-year.
  • APTALIS PHARMA INC costs and expenses for the quarter ending 2010-12-31 was $67.01M.
  • APTALIS PHARMA INC costs and expenses for fiscal 2011 was $536.79M, a 17.15% increase from fiscal 2010.
  • APTALIS PHARMA INC costs and expenses for fiscal 2010 was $458.19M, a 19.53% increase from fiscal 2009.
  • APTALIS PHARMA INC costs and expenses for fiscal 2009 was $383.32M.
Period endCosts and Expenses 3 monthCosts and Expenses 6 monthCosts and Expenses 9 monthCosts and Expenses 12 month
2011-12-31$111.41M
10-Q · filed 2012-02-10
$258.99M
derived: sum of 2 quarters · filed 2012-02-10
$452.65M
derived: sum of 3 quarters · filed 2012-02-10
2011-09-30$147.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20
$341.25M
derived: sum of 2 quarters · filed 2011-12-20
$536.79M
10-K · filed 2011-12-20
2011-06-30$193.67M
10-Q · filed 2011-08-12
$389.21M
10-Q · filed 2011-08-12
2010-12-31$67.01M
10-Q · filed 2012-02-10
$133.40M
derived: sum of 2 quarters · filed 2012-02-10
$213.96M
derived: sum of 3 quarters · filed 2012-02-10
2010-09-30$66.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20
$146.96M
derived: sum of 2 quarters · filed 2011-12-20
$458.19M
10-K · filed 2011-12-20
2010-06-30$80.56M
10-Q · filed 2011-08-12
$391.80M
10-Q · filed 2011-08-12
2009-09-30$383.32M
10-K · filed 2011-12-20